MDM2 and osteosarcoma: Is an H3-3A mutation or an MDM2 amplification detected in a conventional high-grade osteosarcoma, furthermore, sufficient to suggest a malignant giant cell tumor or a low-grade central osteosarcoma with high-grade transformation [43]?